Drug
Asp388b
Asp388b: highest development phase Phase 1/2, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASP388B NCT07730021 | Phase 1/2 | Locally Advanced or Metastatic Solid Tumors |
Latest
No recent events.
Follow Asp388b on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.